InvestorsHub Logo
Followers 1
Posts 147
Boards Moderated 0
Alias Born 03/14/2014

Re: None

Monday, 03/21/2016 5:08:04 PM

Monday, March 21, 2016 5:08:04 PM

Post# of 140478
If this financing deal is truly considered the "last one," then theoretically that'd be the end of the abyss and it'd be all up from here, assuming CE, FDA, and sales go smooth.

If you believe this financing is that "last one," time to gobble up the shares tomorrow and for the next few days. Between us on this forum and all the SAGES visitors, who knows, people might see it as the final buying opportunity. I'm more interested in seeing what our new cash burn is with the new PR and ending device production.

I love this device and we can all speculate about mgmt., but in the end, this is a development stock. You really have to play a lot of poker at the Aria to have the guts to be long and strong on OTC biotech plays. A lower price tomorrow might be the entry point that attracts new big investors. Consider me an optimist. We're rounding the final corner.